Browse All
Displaying 6 - 10 of 11
Author:Bose, Gauruv Greene, Nupur Healy, Brian Weiner, Howard Farnett, Lisa Higuchi, Keiko Chitnis, Tanuja
Session Name:P5: MS Prognosis/Epidemiology
Topic:MS and Inflammatory Disease
Program Number:P5.006
Author Institution:Brigham and Women’s Hospital and University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada Sanofi, Cambridge, MA Brigham and Women's Hospital, Boston, MA Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Author:Howard, Danielle Lokhande, Hrishikesh Healy, Brian De Las Heras, Virginia Arnould, Sophie Glanz, Bonnie Zurawski, Jonathan Polgar-Turcsanyi, Mariann Saraceno, Taylor Weiner, Howard Chitnis, Tanuja
Program Number:P5.014
Author Institution:Brigham and Women's Hospital, Boston, MA Novartis Pharma AG, Basel, Switzerland
Author:Bose, Gauruv Greene, Nupur Healy, Brian C. Weiner, Howard Farnett, Lisa Higuchi, Keiko Chitnis, Tanuja
Program Number:P5.018
Author Institution:Brigham and Women’s Hospital and University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada Sanofi, Cambridge, MA Brigham and Women’s Hospital Boston, Boston, MA Brigham and Women's Hospital and Harvard Medical School, Boston, MA Sanofi, San Antonio, TX
Author:Williams, Mitzi Airas, Laura Chitnis, Tanuja Saini, Sarbjit Hide, Michihiro Sussman, Gordon Nakahara, Jin Bermel, Robert Dörner, Thomas Loop, Brett Ziehn, Marina Willi, Roman Kieseier, Bernd C. Nikolaev, Ivan Haemmerle, Sibylle Zharkov, Artem Siegel, Richard Cenni, Bruno Wiendl, Heinz Maurer, Marcus Giménez-Arnau, Ana Montalban, Xavier
Session Name:P7: MS Therapeutics 1
Program Number:P7.015
Author Institution:Joi Life Wellness Group, Atlanta, GA, USA, Atlanta, GA Turku University Hospital and University, Finland, Turku, Finland Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA, Boston, MA Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA, Baltimore, MD Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, Hiroshima, Japan University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin DRFZ, Berlin, Germany, Berlin, Germany Novartis Pharmaceutical Corporation, Cambridge, MA, USA, Cambridge, MA Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Novartis Pharma AG, Basel, Switzerland Department of Neurology, Heinrich-Heine University, Duesseldorf, Germany, Duesseldorf, Germany Novartis Institutes for Biomedical Research, Basel, Switzerland, Basel, Switzerland Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, Muenster, Germany Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, Berlin, Germany Department of Dermatology, Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain, Barcelona, Spain Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain
Author:Drew, William Kletenik, Isaiah Bakshi, Rohit Cavallari, Michele Chitnis, Tanuja Glanz, Bonnie Guttmann, Charles Palotai, Miklos Fox, Michael Siddiqi, Shan
Session Name:P11: MS Neuroimaging 2
Program Number:P11.014
Author Institution:Brigham and Women's Hospital, Boston, MA
